La Candelaria Hospital presents campaign ‘Your Red Line 55’

The service of Cardiology of Nuestra Señora de Candelaria University Hospitalcenter attached to the Ministry of Health of the Canary Islands, has presented the campaign ‘Your red line 55’, which has the collaboration of Cardioaliance and Novartis.

This initiative seeks to raise patients who have suffered a Myocardial infarction about the importance of reducing LDL cholesterol (commonly called ‘bad cholesterol’) to 55 mg/dl to avoid a new event. The initiative will take place until September 13 at the Hospital Hall and is complemented by an interactive platform that has tools such as a downloadable guide to interpret the analytics.

The director of the Health Area of ​​Tenerife, Diana Mora, He said that “this campaign is key to promoting healthy habits and accompanying patients in secondary prevention after a heart attack, helping them maintain a safer and quality life. From the Canarian health service we reaffirm our commitment to health education, the promotion of healthy habits and collaboration with professionals and associations to accompany those who have suffered a heart attack in their way to a healthier life.”

The Head of the Cardiology ServiceJulio HernándezHe explained that secondary prevention is essential because, “after a first heart attack, the risk of suffering a new cardiovascular event is very high, especially in the first months.” For his part, the president of Cardioaliance, Tomas Fajardohe stressed that, “adopt healthy life habits And actively follow medical recommendations is crucial for people who have suffered a recent cardiovascular event. ”

One in four people who has had a myocardial infarction experience another vascular event Atherosclerotic in the following two years, so, to avoid this, it is recommended that those with a very high risk of this event maintain a level of LDL cholesterol. However, more than 80% of patients with this established pathology do not meet this objective3, a relevant fact taking into account that it is the main modifiable and causal factor of atherosclerotic vascular disease (EVA).

Eva refers to a variety of pathologies caused by the development and growth of plaques in the internal lining of the arteries. The atherosclerotic plaque is mainly composed of low density lipoproteins attached (C-LDL) that accumulates over time. The accumulated exposure to the C-LDL is proportionally related to the growth of the arterial plaque and its progression causes subsequent risk of cardiovascular events such as infarction or stroke.

The Director of Communication and Patients of Novartis SpainEsther Espinosaaffirms that “in Novartis we go beyond the development of innovative medicines. We aspire to be agents of change in society, promoting prevention as a fundamental tool to combat one of the main causes of mortality in our population.”